Table 3.
Fibrinolytic Therapy Cohort |
PCI Cohort |
|||
---|---|---|---|---|
minutes/year | p | minutes/year | p | |
Average | −0.01 | 0.956 | −0.58 | 0.094 |
Geographic location | >.500 | 0.046 | ||
New England | 0.2 | −7.5 | ||
Middle Atlantic | 0.2 | 0.8 | ||
South Atlantic | 0.3 | −0.5 | ||
East North Central | −0.3 | −0.5 | ||
East South Central | 0.1 | −0.7 | ||
West North Central | −0.5 | −1.6 | ||
West South Central | 0.3 | 0.4 | ||
Mountain | −0.2 | 1.1 | ||
Pacific | 0.0 | −0.6 | ||
Ownership | 0.152 | 0.329 | ||
Public | −0.2 | 0.8 | ||
Not-for-profit | −0.1 | −0.6 | ||
Private | 0.8 | −1.6 | ||
Teaching | >.500 | >.500 | ||
Urban/teaching | 0.1 | −0.6 | ||
Urban/nonteaching | 0.2 | −0.3 | ||
Rural/teaching | 0.2 | −1.7 | ||
Rural/nonteaching | −0.1 | −3.1 | ||
Facilities | >.500 | 0.271 | ||
Open-heart surgery program | 0.3 | −0.5 | ||
Cardiac catheterization lab only | −0.2 | −1.9 | ||
Other | −0.1 | − | ||
Annual volume | >.500 | 0.016 | ||
<20 LYS or <15 PCI | 0.1 | 1.0 | ||
20-40 LYS or 15-50 PCI | 0.0 | −0.1 | ||
>40 LYS or >50 PCI | 0.0 | −1.9 | ||
Reperfusion specialization | 0.086 | 0.294 | ||
%LYS or %PCI <20% | 6.0 | −2.3 | ||
%LYS or %PCI 20%-90% | 0.6 | −0.4 | ||
%LYS or %PCI > 90% | −0.3 | −1.9 |
Adjusted for patient characteristics (from Table 1)
LYS=fibrinolytic therapy; PCI=percutaneous coronary intervention